Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

A key limitation of the use of the CRISPR–Cas9 system for genome editing and other applications is the requirement that a protospacer adjacent motif (PAM) be present at the target site. For the most commonly used Cas9 from Streptococcus pyogenes (SpCas9), the required PAM sequence is NGG. No natural or engineered Cas9 variants that have been shown to function efficiently in mammalian cells offer a PAM less restrictive than NGG. Here we use phage-assisted continuous evolution to evolve an expanded PAM SpCas9 variant (xCas9) that can recognize a broad range of PAM sequences including NG, GAA and GAT. The PAM compatibility of xCas9 is the broadest reported, to our knowledge, among Cas9 proteins that are active in mammalian cells, and supports applications in human cells including targeted transcriptional activation, nuclease-mediated gene disruption, and cytidine and adenine base editing. Notably, despite its broadened PAM compatibility, xCas9 has much greater DNA specificity than SpCas9, with substantially lower genome-wide off-target activity at all NGG target sites tested, as well as minimal off-target activity when targeting genomic sites with non-NGG PAMs. These findings expand the DNA targeting scope of CRISPR systems and establish that there is no necessary trade-off between Cas9 editing efficiency, PAM compatibility and DNA specificity.

[1]  J. Keith Joung,et al.  Activation of prokaryotic transcription through arbitrary protein–protein contacts , 1997, Nature.

[2]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[3]  S. Wolfe,et al.  Identifying DNA sequences recognized by a transcription factor using a bacterial one-hybrid system , 2006, Nature Protocols.

[4]  David R. Liu,et al.  Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro Selection , 2011, Nature Methods.

[5]  David R. Liu,et al.  A System for the Continuous Directed Evolution of Biomolecules , 2011, Nature.

[6]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[7]  George Church,et al.  Optimization of scarless human stem cell genome editing , 2013, Nucleic acids research.

[8]  M. Jinek,et al.  Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease , 2014, Nature.

[9]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[10]  Feng Gu,et al.  Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells , 2014, Scientific Reports.

[11]  Meagan E. Sullender,et al.  Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation , 2014, Nature Biotechnology.

[12]  Jay Shendure,et al.  Saturation Editing of Genomic Regions by Multiplex Homology-Directed Repair , 2014, Nature.

[13]  Ron Weiss,et al.  Highly-efficient Cas9-mediated transcriptional programming , 2014, Nature Methods.

[14]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[15]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[16]  Jennifer A. Doudna,et al.  Conformational control of DNA target cleavage by CRISPR–Cas9 , 2015, Nature.

[17]  David R. Liu,et al.  Continuous directed evolution of DNA-binding proteins to improve TALEN specificity , 2015, Nature Methods.

[18]  David R. Liu,et al.  Development of potent in vivo mutagenesis plasmids with broad mutational spectra , 2015, Nature Communications.

[19]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.

[20]  Martin J. Aryee,et al.  GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.

[21]  A. Regev,et al.  Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System , 2015, Cell.

[22]  Martin J. Aryee,et al.  Engineered CRISPR-Cas9 nucleases with altered PAM specificities , 2015, Nature.

[23]  J. Joung,et al.  Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition , 2015, Nature Biotechnology.

[24]  David A. Scott,et al.  Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.

[25]  David R. Liu,et al.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.

[26]  Gang Bao,et al.  The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  J. Keith Joung,et al.  731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects , 2016 .

[28]  Maximilian Müller,et al.  Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  Ping Wang,et al.  Continuous evolution of Bacillus thuringiensis toxins overcomes insect resistance , 2016 .

[30]  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage , 2017, Nature.

[31]  Jennifer A. Doudna,et al.  Enhanced proofreading governs CRISPR-Cas9 targeting accuracy , 2017, Nature.

[32]  Jaewoong Hwang,et al.  Rescue of high-specificity Cas9 variants using sgRNAs with matched 5’ nucleotides , 2017, Genome Biology.

[33]  Eunji Kim,et al.  In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni , 2017, Nature Communications.

[34]  Kevin T. Zhao,et al.  Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity , 2017, Science Advances.

[35]  Jennifer A. Doudna,et al.  Enhanced proofreading governs CRISPR-Cas9 targeting accuracy , 2017, Nature.

[36]  Dieter Söll,et al.  Continuous directed evolution of aminoacyl-tRNA synthetases , 2017, Nature chemical biology.

[37]  Kevin T. Zhao,et al.  Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions , 2017, Nature Biotechnology.

[38]  Feng Zhang,et al.  Engineered Cpf1 variants with altered PAM specificities increase genome targeting range , 2017, Nature Biotechnology.

[39]  A. Kondo,et al.  Beyond Native Cas9: Manipulating Genomic Information and Function. , 2017, Trends in biotechnology.

[40]  David R. Liu,et al.  Phage-assisted continuous evolution of proteases with altered substrate specificity , 2017, Nature Communications.

[41]  David R. Liu,et al.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes , 2017, Cell.